Scleroderma-Associated Interstitial Lung Disease (SSC-ILD)

1

Review clinical trials related to Scleroderma-Associated Interstitial Lung Disease (SSC-ILD). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies

The purpose of this study is to obtain biologic materials from the blood, airways and/or urine of normal individuals and individuals with lung disease. The normal are used to establish a set of normal ranges for various parameters. These provide control information when compared to individuals with various pulmonary diseases, and will help in understanding of the etiology and pathogenesis of various lung diseases. The underlying hypothesis is that the pathologic morphological changes in the airway epithelium must be preceded by changes in the gene expression pattern of the airway epithelium and potentially in macrophages.

Participants needed: 2,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Weill Medical College of Cornell UniversityUpdated: Nov 14, 2025Locations: 1
Eligibility criteria

All study subjects should be able to provide informed consent [+12]

Individuals not deemed in good overall health by the investigator during screeni... [+10]